Periodontal Treatment and Glycemic Control

July 15, 2013 updated by: Salman Aziz, Pakistan Institute of Medical Sciences

Impact of Non Surgical Periodontal Treatment on Glycemic Control in Type II Diabetics

The purpose of this study is to determine the effects of non surgical periodontal treatment on glycemic control in type II diabetics.

Study Overview

Status

Unknown

Detailed Description

The selected patients in treatment group will be given mechanical periodontal treatment in the form of scaling and root planning while the non intervention group patients will not receive treatment until the end of the trial.

Study Type

Interventional

Enrollment (Actual)

184

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Federal Capital
      • Islamabad, Federal Capital, Pakistan, 54000
        • Pakistan Institute of Medical Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed patients of Type 2 Diabetes Mellitus for at least 2 years
  • HbA1C values >6.5 % as per ADA criteria
  • non smokers
  • Patients with at least 16 standing teeth
  • At least 8 teeth with one site having Mild to Moderate periodontal disease

Exclusion Criteria:

  • Smokers
  • Type 2 Diabetics with complications e.g. renal, ophthalmic etc
  • Patients with chronic infections
  • Patients who get hospitalized or have to change their medications during the course of study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Periodontal Treatment

Periodontal Treatment in the form of Full mouth scaling and root planning will be given at one time only i.e. at baseline after full mouth dental checkup.

Checkup will be repeated at 3, 6 & 9 month interval along with HbA1C levels

one time intervention in the form of scaling and root planing
No Intervention: Non treatment group
this group will only receive detailed dental check ups at the specified time 0, 3, 6 and 9 months respectively and there will be no scaling done. HbA1C levels will be estimated at the above specified times

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in HbA1C levels from base line at 3, 6 and 9 months
Time Frame: 3 months, 6 months, 9 months
HbA1C levels will be recorded and any change in percentage noted
3 months, 6 months, 9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bleeding on Probing
Time Frame: Base Line, 3 months, 6 months and 9 months
a change in the above mentioned periodontal parameters will be recorded at the specified times Bleeding on probing will be recorded as Yes or No for each tooth
Base Line, 3 months, 6 months and 9 months
Clinical Attachment Loss
Time Frame: Base Line, 3 months, 6 months, 9 months
A change in the above mentioned periodontal parameter will be recorded at the specified times Clinical Attachment loss will be recorded in millimeters for each tooth
Base Line, 3 months, 6 months, 9 months
Periodontal Pocket Depth
Time Frame: Base Line, 3 months, 6 months, 9 months
A change in Periodontal pocket will be measured in millimeters for the above mentioned time frame
Base Line, 3 months, 6 months, 9 months

Other Outcome Measures

Outcome Measure
Time Frame
Fasting Blood Glucose
Time Frame: Base Line, 3, 6 and 9 Months
Base Line, 3, 6 and 9 Months
C-Reactive Protein
Time Frame: Base Line, 3 months, 6 months, 9 months
Base Line, 3 months, 6 months, 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Salman Aziz, FCPS, MFDS, Pakistan Institute of Medical Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Anticipated)

September 1, 2013

Study Completion (Anticipated)

October 1, 2013

Study Registration Dates

First Submitted

June 12, 2013

First Submitted That Met QC Criteria

July 15, 2013

First Posted (Estimate)

July 17, 2013

Study Record Updates

Last Update Posted (Estimate)

July 17, 2013

Last Update Submitted That Met QC Criteria

July 15, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus Type 2

Clinical Trials on Non Surgical Periodontal Treatment

Subscribe